Edition:
India

Arcturus Therapeutics Ltd (ARCT.OQ)

ARCT.OQ on NASDAQ Stock Exchange Global Market

15.82USD
27 Mar 2020
Change (% chg)

$0.57 (+3.74%)
Prev Close
$15.25
Open
$15.00
Day's High
$16.38
Day's Low
$15.00
Volume
36,619
Avg. Vol
35,838
52-wk High
$18.94
52-wk Low
$5.43

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.57 December 28 Mar 2020

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 1 2
(2) OUTPERFORM 5 4 5 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.62 1.57 1.83 1.71

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-20 7 4.97 8.20 1.70 0.60
Quarter Ending Jun-20 7 3.22 4.16 1.70 0.60
Year Ending Dec-20 8 15.61 21.90 6.90 21.80
Year Ending Dec-21 6 16.36 25.00 0.00 31.58
Earnings (per share)
Quarter Ending Mar-20 7 -0.57 -0.30 -0.72 --
Quarter Ending Jun-20 7 -0.69 -0.49 -0.94 --
Year Ending Dec-20 7 -2.71 -2.02 -3.28 -2.07
Year Ending Dec-21 5 -2.28 -1.68 -3.09 -1.74

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-19 3.65 2.97 0.68 18.66
Quarter Ending Sep-19 5.90 3.32 2.58 43.72
Quarter Ending Jun-19 3.36 10.15 6.79 202.10
Quarter Ending Mar-19 3.07 4.35 1.28 41.74
Quarter Ending Dec-18 2.95 7.58 4.62 156.47

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-20 4.97 4.97 3.15 3.10 0.60
Quarter Ending Jun-20 3.22 3.22 3.20 3.17 0.60
Year Ending Dec-20 15.61 15.61 10.86 12.97 21.80
Year Ending Dec-21 16.36 16.36 14.80 23.11 31.58

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-20 0 0 3 1
Quarter Ending Jun-20 0 0 2 2
Year Ending Dec-20 0 0 4 2
Year Ending Dec-21 0 0 0 2
Earnings